Fresenius SE & Co. KGaA (FRE) – Investment Analysts’ Weekly Ratings Changes

Fresenius SE & Co. KGaA (FRA: FRE) recently received a number of ratings updates from brokerages and research firms:

• 7/29/2022 –
• 7/25/2022 – Fresenius SE & Co. KGaA was given a new €30.00 ($30.93) price target on by analysts at Jefferies Financial Group Inc..
• 7/22/2022 – Fresenius SE & Co. KGaA was given a new €52.50 ($54.12) price target on by analysts at Barclays PLC.
• 7/18/2022 – Fresenius SE & Co. KGaA was given a new €33.30 ($34.33) price target on by analysts at JPMorgan Chase & Co..
• 6/27/2022 – Fresenius SE & Co. KGaA was given a new €30.00 ($30.93) price target on by analysts at Jefferies Financial Group Inc..
• 6/23/2022 – Fresenius SE & Co. KGaA was given a new €30.00 ($30.93) price target on by analysts at UBS Group AG.
• 6/21/2022 – Fresenius SE & Co. KGaA was given a new €52.50 ($54.12) price target on by analysts at Barclays PLC.

Fresenius SE & Co. KGaA Price Performance

FRA:FRE opened at €24.80 ($25.57) on Tuesday. Fresenius SE & Co. KGaA has a 52-week low of €60.16 ($62.02) and a 52-week high of €80.00 ($82.47). The stock has a fifty day moving average of €29.12 and a 200 day moving average of €32.26.

Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Recommended Stories

• MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
• The Colgate-Palmolive Growth Outlook Brightens 
• Deep Value High Yield Newell Brands Is Ready To Bottom 
• These Stocks Outperformed Last Time There Was A Recession
• Does Rivian’s Stock Still Have A Future?

Want More Great Investing Ideas?